Determination of cisapride in pharmaceutical dosage forms by reversed-phase liquid chromatography

Journal of Pharmaceutical and Biomedical Analysis

Volumn 21, Issue 1, 1999, Pages 221-226

  Argekar, A P ^a   Sawant, J G ^a  

^a INSTITUTE OF SCIENCE   (India)

Author keywords

Cisapride; Pharmaceutical dosage forms; RP LC

Indexed keywords

CISAPRIDE; CIZA; MOTILAX; UNCLASSIFIED DRUG;

ACCURACY; ANALYTIC METHOD; ARTICLE; DRUG DETERMINATION; DRUG DOSAGE FORM; PRIORITY JOURNAL; REVERSED PHASE LIQUID CHROMATOGRAPHY; SUSPENSION; TABLET;

EID: 0032872332     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0731-7085(99)00095-3     Document Type: Article

References (10)

1. Martindale The Extra Pharmacopoeia. 31st ed. 1996;Royal Pharmaceutical Society of Great Britain, London.
2. British Pharmacopoeia 93. 1996;HMSO, London. Addendum 96.
3. Chandrasekhar T.G., Smrita K., Rao P.S.N., Vyas S.K. J. Planner Chromatogr. Mod-TCC. 9(2):1996;138-141.
4. Sastry C.S.P., Shrinivas Y., Suba Rao P.V. Talanta. 44(4):1997;517-526.
5. Sastry C.S.P., Shrinivas Y., Suba Rao P.V. Mikrochim. Acta. 126(1-2):1997;63-67.
6. Gonzalez Martin M.I., Gonzales Perez C., Blanco Lopez M.A. Anal. Lett. 27(9):1994;1713-1718.
7. R. Woestenborghs, W. Lorreyne, F. Van Rampacy, Heykants, J. Chromatogr. Biomed. Appl. 68 (1 (J. Chromatogr. 424)) (1988) 195-200.
8. Iyer E.K., Tipnis H.P. Indian Drugs. 31(11):1994;519-524.
9. Preechagoon Y., Charles B.G. J. Chromatogr. Biomed. Appl. 670(1):1995;139-143.
10. ICH Topic Q23, Validation of Analytical Procedures: Methodology, Step 4, Consensus Guideline, 6 November 1996. MCA Burodirect Publication No. 281/95, Medicine Control Agency, London, UK.